SCHEMBL18759725

SCHEMBL18759725

Cc1cc(C)c(S(=O)(=O)[O-])cc1C.N#Cc1cc[n+](N)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAD51 Q06609 2/20 0.39
▸ HDAC8 Q9BY41 1/20 0.36
▸ CA1 P00915 3/20 0.34
▸ CA2 P00918 3/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ CA12 O43570 1/20 0.34
▸ LMNA P02545 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ PTGS2 P35354 1/20 0.32
▸ RAPGEF4 Q8WZA2 1/20 0.32
▸ HSD11B1 P28845 2/20 0.31
▸ BRD4 O60885 1/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ BCHE P06276 1/20 0.31
▸ ACHE P22303 1/20 0.31
▸ CYP2A6 P11509 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ GFER P55789 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1810783 0.80 RAPGEF4 (0.38) RAD51HDAC8CA1CA2CA9
SCHEMBL10638597 0.72 LMNA (0.52) LMNATDP1RAPGEF4ALDH1A1GAA
SCHEMBL12346382 0.72 — —
SCHEMBL29983014 0.67 HDAC8 (0.46) RAD51HDAC8CA1CA2CA9
SCHEMBL5831908 0.64 HDAC8 (0.58) HDAC8CA1CA2CA9CA12
SCHEMBL1823536 0.63 RAPGEF4 (0.49) CA1CA2CA9CA12LMNA
SCHEMBL30725489 0.62 CYP3A4 (0.46) LMNATDP1RAPGEF4BRD4ALDH1A1
SCHEMBL176615 0.62 CYP3A4 (0.46) LMNATDP1RAPGEF4BRD4ALDH1A1
SCHEMBL14925398 0.62 PDIA6 (0.47) RAD51CA1CA2CA9CA12
SCHEMBL29212129 0.61 CYP2A6 (0.41) HDAC8CA1CA2ALDH1A1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2493895-B1 N-CONTAINING HETEROARYL DERIVATIVES AS JAK3 KINASE INHIBITORS VECTURA LTD (GB) 2017-04-26 — — EP disclosed
Send feedback